178 related articles for article (PubMed ID: 27195522)
21. DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene.
Harrigan JA; Vezina CM; McGarrigle BP; Ersing N; Box HC; Maccubbin AE; Olson JR
Toxicol Sci; 2004 Feb; 77(2):307-14. PubMed ID: 14691214
[TBL] [Abstract][Full Text] [Related]
22. Dietary restriction modulated carcinogen-DNA adduct formation and the carcinogen-induced DNA strand breaks.
Chou MW; Chen W; Mikhailova MV; Nichols J; Weis C; Jackson CD; Hart RW; Chung KT
Toxicol Lett; 1997 Jun; 92(1):21-30. PubMed ID: 9242354
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of β-catenin signalling promotes DNA damage elicited by benzo[a]pyrene in a model of human colon cancer cells via CYP1 deregulation.
Kabátková M; Zapletal O; Tylichová Z; Neča J; Machala M; Milcová A; Topinka J; Kozubík A; Vondráček J
Mutagenesis; 2015 Jul; 30(4):565-76. PubMed ID: 25805023
[TBL] [Abstract][Full Text] [Related]
24. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation.
Uno S; Dalton TP; Derkenne S; Curran CP; Miller ML; Shertzer HG; Nebert DW
Mol Pharmacol; 2004 May; 65(5):1225-37. PubMed ID: 15102951
[TBL] [Abstract][Full Text] [Related]
25. Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line.
de Waard PW; de Kok TM; Maas LM; Peijnenburg AA; Hoogenboom RL; Aarts JM; van Schooten FJ
Mutagenesis; 2008 Jan; 23(1):67-73. PubMed ID: 18065724
[TBL] [Abstract][Full Text] [Related]
26. The co-carcinogen benzo[e]pyrene increases the binding of a low dose of the carcinogen benzo[a]pyrene to DNA in Sencar mouse epidermis.
Lau HH; Baird WM
Cancer Lett; 1992 Apr; 63(3):229-36. PubMed ID: 1576591
[TBL] [Abstract][Full Text] [Related]
27. Pregnane X receptor protects HepG2 cells from BaP-induced DNA damage.
Naspinski C; Gu X; Zhou GD; Mertens-Talcott SU; Donnelly KC; Tian Y
Toxicol Sci; 2008 Jul; 104(1):67-73. PubMed ID: 18381355
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent benzo(a)pyrene [B(a)P]-DNA adduct levels and persistence in F-344 rats following subchronic dietary exposure to B(a)P.
Ramesh A; Knuckles ME
Cancer Lett; 2006 Aug; 240(2):268-78. PubMed ID: 16288829
[TBL] [Abstract][Full Text] [Related]
29. Modulation of benzo[a]pyrene induced neurotoxicity in female mice actively immunized with a B[a]P-diphtheria toxoid conjugate.
Schellenberger MT; Grova N; Farinelle S; Willième S; Schroeder H; Muller CP
Toxicol Appl Pharmacol; 2013 Sep; 271(2):175-83. PubMed ID: 23684556
[TBL] [Abstract][Full Text] [Related]
30. Integrated Epigenetics, Transcriptomics, and Metabolomics to Analyze the Mechanisms of Benzo[a]pyrene Neurotoxicity in the Hippocampus.
Wang J; Li CL; Tu BJ; Yang K; Mo TT; Zhang RY; Cheng SQ; Chen CZ; Jiang XJ; Han TL; Peng B; Baker PN; Xia YY
Toxicol Sci; 2018 Nov; 166(1):65-81. PubMed ID: 30085273
[TBL] [Abstract][Full Text] [Related]
31. Systems toxicology approach to understand the kinetics of benzo(a)pyrene uptake, biotransformation, and DNA adduct formation in a liver cell model.
Madureira DJ; Weiss FT; Van Midwoud P; Helbling DE; Sturla SJ; Schirmer K
Chem Res Toxicol; 2014 Mar; 27(3):443-53. PubMed ID: 24446834
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of liver microsome-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in the rat following glucose administration.
Vance RE; Teel RW; Strother A
Cancer Lett; 1990 Apr; 50(2):149-56. PubMed ID: 2109652
[TBL] [Abstract][Full Text] [Related]
33. Identification of essential transcription factors for adequate DNA damage response after benzo(a)pyrene and aflatoxin B1 exposure by combining transcriptomics with functional genomics.
Smit E; Souza T; Jennen DGJ; Kleinjans JCS; van den Beucken T
Toxicology; 2017 Sep; 390():74-82. PubMed ID: 28882572
[TBL] [Abstract][Full Text] [Related]
34. Alteration of benzo(a)pyrene biotransformation by resveratrol in Apc
Huderson AC; Rekha Devi PV; Niaz MS; Adunyah SE; Ramesh A
Invest New Drugs; 2019 Apr; 37(2):238-251. PubMed ID: 29931584
[TBL] [Abstract][Full Text] [Related]
35. Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity.
Maier A; Schumann BL; Chang X; Talaska G; Puga A
Mutat Res; 2002 May; 517(1-2):101-11. PubMed ID: 12034312
[TBL] [Abstract][Full Text] [Related]
36. 32P-postlabeling analysis of DNA adduct formation and persistence in English sole (Pleuronectes vetulus) exposed to benzo[a]pyrene and 7H-dibenzo[c,g]carbazole.
Stein JE; Reichert WL; French B; Varanasi U
Chem Biol Interact; 1993 Jul; 88(1):55-69. PubMed ID: 8330324
[TBL] [Abstract][Full Text] [Related]
37. Epidermal cytokinetics, DNA adducts, and dermal inflammation in the mouse skin in response to repeated benzo[a]pyrene exposures.
Albert RE; Miller ML; Cody TE; Talaska G; Underwood P; Andringa A
Toxicol Appl Pharmacol; 1996 Jan; 136(1):67-74. PubMed ID: 8560481
[TBL] [Abstract][Full Text] [Related]
38. Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats.
Stiborová M; Dračínská H; Bořek-Dohalská L; Klusoňová Z; Holecová J; Martínková M; Schmeiser HH; Arlt VM
Toxicology; 2018 May; 400-401():48-56. PubMed ID: 29649501
[TBL] [Abstract][Full Text] [Related]
39. The relationship between DNA adduct formation by benzo[a]pyrene and expression of its activation enzyme cytochrome P450 1A1 in rat.
Hodek P; Koblihová J; Kizek R; Frei E; Arlt VM; Stiborová M
Environ Toxicol Pharmacol; 2013 Nov; 36(3):989-96. PubMed ID: 24095716
[TBL] [Abstract][Full Text] [Related]
40. Toxicogenomic outcomes predictive of forestomach carcinogenesis following exposure to benzo(a)pyrene: relevance to human cancer risk.
Labib S; Guo CH; Williams A; Yauk CL; White PA; Halappanavar S
Toxicol Appl Pharmacol; 2013 Dec; 273(2):269-80. PubMed ID: 23735875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
